Inhalation of Stachybotrys chartarum causes pulmonary arterial hypertension in mice

International Journal of Experimental Pathology

Volumn 89, Issue 3, 2008, Pages 201-208

  Ochiai, Eri ^a   Kamei, Katsuhiko ^a   Watanabe, Akira ^a,b   Nagayoshi, Masaru ^a   Tada, Yuji ^a   Nagaoka, Tetsutaro ^c   Sato, Koichi ^c   Sato, Ayaka ^a   Shibuya, Kazutoshi ^d  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fungi; Intratracheal injection; Mouse; Pulmonary arterial hypertension

Indexed keywords

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY WALL; ARTICLE; CONTROLLED STUDY; FUNGUS SPORE; HEMODYNAMICS; HISTOPATHOLOGY; INHALATION; INTIMA; LUNG BLOOD VESSEL; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STACHYBOTRYS CHARTARUM; SYSTOLIC BLOOD PRESSURE; TUNICA MEDIA;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; HEMODYNAMICS; HYPERTENSION, PULMONARY; INHALATION EXPOSURE; LUNG DISEASES, FUNGAL; MALE; MICE; MICE, INBRED STRAINS; PULMONARY ARTERY; SPORES, FUNGAL; STACHYBOTRYS; VIRULENCE;

EID: 43349100844     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2008.00585.x     Document Type: Article

References (32)

1. Bauer N.R., Moore T.M., McMurtry I.F. (2007) Rodent models of PAH: are we there yet? Am. J. Physiol. Lung Cell Mol. Physiol. 293, L580 L582.
2. Centers for Disease Control and Prevention (1997) Update: pulmonary hemorrhage/hemosiderosis among infants-Cleveland, Ohio, 1993-1996. Morb. Mortal. Wkly Rep. 46, 33 35.
3. Centers for Disease Control and Prevention. (2000) Update: pulmonary hemorrhage/hemosiderosis among infants-Cleveland, Ohio, 1993-1996. Morb. Mortal. Wkly Rep. 49, 180 184. Erratum in: (2000) Morb. Mortal. Wkly. Rep. 49, 213.
4. Cole R.J., Jarvis B.B., Schweikert M.A. (2003) Handbook of Secondary Fungal Metabolites, Vol. 3. London: Academic Press, pp. 672.
5. Dai Z.K., Tan M.S., Chai C.Y. et al. (2004) Upregulation of endothelial nitric oxide synthase and endothelin-1 in pulmonary hypertension secondary to heart failure in aorta-banded rats. Pediatr. Pulmonol. 37, 249 256.
6. Fagan K.A., Fouty B.W., Tyler R.C. et al. (1999) The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J. Clin. Invest. 103, 291 299.
7. Fueta Y., Kunugita N., Schwarz W. (2005) Antiepileptic action induced by a combination of vigabatrin and tiagabine. Neuroscience 132, 335 345.
8. Gaine S.P. Rubin L.J. (1998) Primary pulmonary hypertension. Lancet 352, 719 725.
9. Giaid A., Yanagisawa M., Langleben D. et al. (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N. Engl. J. Med. 328, 1732 1739.
10. Guignabert C., Izikki M., Tu L.I. et al. (2006) Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension. Circ. Res. 98, 1323 1330.
11. Heath D. (1992) The rat is a poor animal model for the study of human pulmonary hypertension. Cardioscience 3, 1 6.
12. Heath D. Edwards J.E. (1958) The pathology of hypertensive pulmonary vascular disease. Circulation 18, 533 547.
13. Humbert M., Nunes H., Sitbon O. et al. (2001) Risk factors for pulmonary arterial hypertension. Clin. Chest Med. 22, 459 475.
14. Kuhn R.C., Trimble M.W., Hofer V., Lee M., Nassof R.S. (2005) Prevalence and airborne spore levels of Stachybotrys spp. in 200 houses with water incursions in Houston, Texas. Can. J. Microbiol. 51, 25 28.
15. Marsboom G.R. Janssens S.P. (2004) Models for pulmonary hypertension. Drug Discov. Today: Disease Models 1, 289 296.
16. Maruyama H., Watanabe S., Kimura T. et al. (2007) Granulocyte colony-stimulating factor prevents progression of monocrotaline-induced pulmonary arterial hypertension in rats. Circ. J. 71, 138 143.
17. McLaughlin V.V., Shillington A., Rich S. (2002) Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. Circulation 106, 1477 1482.
18. McLaughlin V.V., Sitbon O., Badesch D.B. et al. (2005) Survival with first-line bosentan in patients with primary pulmonary hypertension. Eur. Respir. J. 25, 244 249.
19. Meyer R.E. Fish R.E. (2005) A review of tribromoethanol anesthesia for production of genetically engineered mice and rats. Lab. Anim. 34, 47 52.
20. Miller J.D. (1992) Fungi as contaminants in indoor air. Atmos. Environ. 26A, 2163 2172.
21. Ochiai E., Kamei K., Hiroshima K. et al. (2005) The pathogenicity of Stachybotrys chartarum. Jpn. J. Med. Mycol. 46, 109 117.
22. Oka M., Homma N., Taraseviciene-Stewart L. et al. (2007) Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ. Res. 100, 923 929.
23. Okuda-Ashitaka E., Minami T., Tachibana S. et al. (1998) Nocistain, a peptide that blocks nociceptin action in pain transmission. Nature 392, 286 289.
24. Pullamsetti S., Kiss L., Ghofrani H.A. et al. (2005) Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension. FASEB J. 19, 1175 1177.
25. Raiesdana A. Loscalzo J. (2006) Pulmonary arterial hypertension. Ann. Med. 38, 95 110.
26. Rosenblum Lichtenstein J.H., Molina R.M., Donaghey T.C., Brain J.D. (2006) Strain differences influence murine pulmonary responses to Stachybotrys chartarum. Am. J. Respir. Cell Mol. Biol. 35, 415 423.
27. Rudarakanchana N., Trembath R.C., Morrell N.W. (2001) New insights into the pathogenesis and treatment of primary pulmonary hypertension. Thorax 56, 888 890.
28. Samson R.A., Hoekstra E.S., Frisvad J.C., eds 2004) Identification of the common food-borne fungi. In: Introduction to Food- and Airborne Fungi, 7th edn. pp. 258 259 (eds R.A. Samson, E.S. Hoekstra, J.C. Frisvad Utrecht: Centraalbureau voor Schimmelcultures.
29. Shelton B.G., Kirkland K.H., Flanders W.D., Morris G.K. (2002) Profiles of airborne fungi in buildings and outdoor environments in the United States. Appl. Environ. Microbiol. 68, 1743 1753.
30. Sorenson W.G., Frazer D.G., Jarvis B.B., Simpson J., Robinson V.A. (1987) Trichothecene mycotoxins in aerosolized conidia of Stachybotrys atra. Appl. Environ. Microbiol. 53, 1370 1375.
31. Swain S.D., Han S., Harmsen A., Shampeny K., Harmsen A.G. (2007) Pulmonary hypertension can be a sequela of prior pneumocystis pneumonia. Am. J. Pathol. 171, 790 799.
32. West J., Fagan K., Steudel W. et al. (2004) Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle. Circ. Res. 94, 1109 1114.